Hypophosphatasia. Review of clinical cases published in the Russian Federation
E.Yu. Gurkina1, V.Yu. Voinova2, L.M. Kuzenkova3, I.B. Sosnina4, A.V. Vitebskaya5, M.M. Kostik6, N.S. Shatokhina7, I.Yu. Chernyak7, E.B. Khramova8, E.S. Romanenko9, A.S. Vyatkina10, A.V. Abrukova11
1V.A. Almazov National Medical Research Center, Saint Petersburg
2Veltischev Research and Clinical Institute for Pediatrics of the Pirogov Russian National Research Medical University, Moscow
3National Medical Research Center for Children’s Health, Moscow
4Children’s Consultative and Diagnostic Center, Saint Petersburg
5Clinical Institute of Child Health named after N.F. Filatov of the First Moscow State Medical University named after I.M. Sechenov (Sechenov University), Moscow
6Saint-Petersburg State Pediatric Medical University, Saint Petersburg
7Children’s Regional Clinical Hospital, Krasnodar
8Tumen State Medical University, Tumen
9South Ural State Medical University, Chelyabinsk
10Children’s Regional Clinical Hospital, Perm
11Presidential Perinatal Center, Cheboksary
Hypophosphatasia (HPP) is a rare polymorphic disease that has different clinical manifestations depending on the age during disease onset and its severity. A wide range of symptoms affects various organs and systems, such as the musculoskeletal system (bones, muscles, joints), respiratory system, nervous system and kidneys, which can have a significant impact on the patient’s physical health and life quality. The prevalence of severe HPP in the European population is known, however, it is difficult to assess the prevalence of milder HPP forms due to the significant heterogeneity of clinical manifestations and the lower frequency of diagnosis. The review provides a modern view concerning HPP etiology and pathogenesis, as well as discusses diagnostic criteria and treatment options. Data from published clinical cases of HPP are also presented. Thus, as of 2020, Russian medical literature described 16 cases of children with the diagnosis of hypophosphatasia. The analysis of clinical cases published in Russian medical scientific journals has shown recommendation expediency to assess the level of tissue-specific alkaline phosphatase in the presence of any bone pathology with rickets-like manifestations in the patient.
Keywords: hypophosphatasia, HPP, tissue-specific alkaline phosphatase, TNSALP, ALPL gene, asfotase alfa, rickets-like diseases.
For citation: Gurkina E.Yu., Voinova V.Yu., Kuzenkova L.M. et al. Hypophosphatasia. Review of clinical cases published in the Russian Federation. RMJ. 2021;2:42–48.
